Diabetic Cystopathy Occurs Independently From Other Atherosclerotic Risks [PDF]
Case Reports in Neurology, 2021 It has not yet been clarified whether atherosclerotic risks other than diabetes are related to bladder small fiber neuropathy (cystopathy) in type 2 diabetes. The aim of this study was to answer this question by urodynamics.
Fuyuki Tateno +2 more
exaly +7 more sources
Imbalance of bladder neurohomeostasis by Myosin 5a aggravates diabetic cystopathy [PDF]
Molecular MedicineBackground Diabetic cystopathy (DCP) is linked to bladder nerve conduction disorders, with diabetes-induced neuropathy impairing nerve signal transmission and causing bladder dysfunction.
Yao Zhang +12 more
doaj +4 more sources
Diabetic cystopathy preceding renal microabscess with papillary necrosis [PDF]
The Korean Journal of Internal Medicine, 2022 Chaiho Jeong +3 more
doaj +4 more sources
Substantiation of the Results of Morphological Examination of the Urinary Bladder Wall in Experimental Diabetic Cystopathy [PDF]
Galician Medical Journal, 2019 Measurement of consumed water and daily diuresis proved the pathomorphological manifestations of streptozotocin-induced cystopathy in the experiment on rats according to the results of biochemical studies of blood and urine.
Nadiya Tokaruk
exaly +5 more sources
Diabetic Cystopathy—What Does It Mean? [PDF]
Journal of Urology, 2009 TYPE 2 diabetes and lower urinary tract dysfunction in women increase with age, and are common, chronic and costly disorders.1 The prevalence of diabetes appears to be increasing in recent years with an estimated 19.3 million American adults having diabetes and another 54 million having pre-diabetes or impaired fasting glucose as defined by a fasting ...
Jeanette S. Brown
exaly +4 more sources
Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model [PDF]
Stem Cell Research & Therapy, 2020 Background Diabetic cystopathy (DCP) is a chronic complication of diabetes mainly within the submucosal and muscular layers of the bladder due to the hyperglycemia-induced ischemia. As no effective therapies are currently available, the administration of
Yi Huang +8 more
doaj +2 more sources
Circulating exosomal miR-16-5p and let-7e-5p are associated with bladder fibrosis of diabetic cystopathy [PDF]
Scientific ReportsDiabetic cystopathy (DCP) is a prevalent etiology of bladder dysfunction in individuals with longstanding diabetes, frequently leading to bladder interstitial fibrosis. Research investigating the initial pathological alterations of DCP is notably scarce.
Bo Xue +6 more
doaj +2 more sources
Implantable Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Single-Institution Retrospective Study [PDF]
International Neurourology JournalPurpose Neurogenic lower urinary tract dysfunction (NLUTD) is highly prevalent among patients with neurologic disorders. Some studies have demonstrated that implantable neuromodulation can improve symptoms of NLUTD.
Karis Buford +7 more
doaj +2 more sources
Association between post-void residual urine volume trajectories and incident urinary tract infection in patients receiving maintenance hemodialysis [PDF]
BMC NephrologyBackground Patients receiving maintenance hemodialysis (MHD) have a markedly increased incidence of urinary tract infection (UTI) because of impaired immune function, reduced urine output, and complications related to medical procedures.
Wen-Jing Yan +3 more
doaj +2 more sources
The Effect of Low-Intensity Extracorporeal Shockwave Treatment on the Urinary Bladder in an Experimental Diabetic Rat Model [PDF]
International Neurourology Journal, 2021 Purpose Preclinical data increasingly support an impact of low-intensity extracorporeal shockwave therapy (Li-ESWT) on the bladder. We investigated the molecular effects of Li-ESWT on the bladder of a streptozotocin-induced diabetic rat model.
Fotios Dimitriadis +5 more
doaj +1 more source